NCT03823274View on ClinicalTrials.gov

Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients

CompletedOBSERVATIONAL

Enrollment

1,011

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

January 3, 2022

Study Completion Date

January 3, 2022

Conditions

Ischemic Stroke

Interventions

DRUG

Aspirin, Clopidogrel

to evaluate the relationship of stroke recurrence and anti-platelet resistance in ischemic stroke patients receiving aspirin and clopidogrel

Trial Locations (1)

Unknown

Chungnam National University Hospital, Daejeon

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY

NCT03823274 - Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients | Biotech Hunter | Biotech Hunter